Résumé
Recently, it was revealed that the high-risk, poor-prognosis downregulation of GABA type A receptor-associated protein (GABARAP) causes a defect in both autophagy and surface exposure of calreticulin (CALR) in multiple myeloma (MM) cells responding to bortezomib. Hence, GABARAP-defective MM cells fail to undergo immunogenic cell death.
langue originale | Anglais |
---|---|
Numéro d'article | 2360275 |
journal | OncoImmunology |
Volume | 13 |
Numéro de publication | 1 |
Les DOIs |
|
état | Publié - 1 janv. 2024 |
Modification externe | Oui |